<DOC>
	<DOCNO>NCT00717197</DOCNO>
	<brief_summary>The purpose study determine capecitabine effective treatment high grade glioma return complete treatment .</brief_summary>
	<brief_title>Study Capecitabine Treat Recurrent High Grade Gliomas</brief_title>
	<detailed_description>High grade glioma ( HGGs ) represent heterogenous group primary brain tumor share WHO grade III IV classification ( anaplastic astrocytoma , anaplastic oligodendroglioma , anaplastic mixed glioma , glioblastoma multiforme ) . Despite upfront use surgery , radiation , chemotherapy , high grade glioma uniformly result recurrence death . Palliative chemotherapy offer improvement time progression , symptom control , quality life , potential survival ; however , establish chemotherapy regimen recurrence exist new treatment need . Oral capecitabine rationale strategy therapeutic palliation recurrent high grade glioma give oral administration , well-known kinetics toxicity , non-competitive toxicity high grade glioma treatment , well establish management algorithm , establish evidence entry central nervous system , evidence safety efficacy malignancy central nervous system .</detailed_description>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>Histological confirmation high grade glioma ( WHO grade III IV : anaplastic astrocytoma , anaplastic oligodendroglioma , anaplastic mixed glioma , glioblastoma multiforme ) Male female 18 year age older Negative pregnancy test ( childbearing potential ) Any number previous recurrence allow Karnofsky Performance Status &gt; 60 Hematocrit &gt; 30,000 White blood cell count &gt; 1,500 Platelet &gt; 100,000 Absolute Neutrophil Count &gt; 1,000 Bilirubin &lt; 1.5 x upper limit normal Transaminases ( ALT AST ) &lt; 1.5 x upper limit normal Creatinine &lt; 1.5 x upper limit normal Adequate medical health participate study Adequate documentation menopause ( natural/surgical ) patient commitment routine use reliable birth control ( barrier/hormonal ) Ability read understand inform consent document Ability willingness follow requirement study include follow direction , take medication prescribe complete diary form Karnofsky Performance Status &lt; 60 Hematocrit &lt; 30,000 White blood cell count &lt; 1,500 Platelet &lt; 100,000 Absolute Neutrophil Count &lt; 1,000 Bilirubin &gt; 1.5 x upper limit normal Transaminases ( ALT AST ) &gt; 1.5 x upper limit normal Creatinine &gt; 1.5 x upper limit normal Inability undergo gadoliniumcontrasted MRIs , include severe claustrophobia insufficient allergy prophylaxis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>HGG</keyword>
	<keyword>anaplastic astrocytoma</keyword>
	<keyword>anaplastic oligodendroglioma</keyword>
	<keyword>anaplastic mixed glioma</keyword>
	<keyword>glioblastoma multiforme</keyword>
	<keyword>GBM</keyword>
	<keyword>Xeloda</keyword>
	<keyword>capecitabine</keyword>
</DOC>